Alexion to Acquire Rare Disease Specialist Wilson Therapeutics
By Natasha Piper
Pharma Deals Review: Vol 2018 Issue 4 (Table of Contents)
Published: 26 Apr-2018
DOI: 10.3833/pdr.v2018.i4.2322 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Alexion Pharmaceuticals has made an all-cash offer to acquire Wilson Therapeutics for a total of SEK7...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018